US Stock MarketDetailed Quotes

AZN AstraZeneca

Watchlist

81.270
-0.080-0.10%

Trading Aug 9 12:33 ET

251.98BMarket Cap39.45P/E (TTM)

AstraZeneca Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

Net income from continuing operations

14.80%2.4B

23.78%2.8B

175.85%6.9B

15.30%897M

78.98%1.65B

745.34%2.09B

309.04%2.26B

1,043.77%2.5B

222.33%778M

146.13%923M

Other non cash items

73.76%702M

-150.70%-356M

127.07%1.45B

142.04%927M

58.79%262M

308.08%404M

-1,675.00%-142M

-52.38%639M

-49.41%383M

-37.50%165M

Change In working capital

86.96%-129M

-288.02%-455M

-92.01%300M

-49.83%150M

-15.93%897M

-268.48%-989M

-86.59%242M

85.90%3.76B

811.90%299M

-11.53%1.07B

-Change in receivables

----

-5.63%-1.43B

----

-40.37%-1.35B

----

-Change in inventory

----

-116.98%-669M

----

149.90%3.94B

----

Cash from discontinued investing activities

Operating cash flow

79.57%3.09B

-20.65%2.49B

5.48%10.35B

-0.75%2.38B

6.28%3.11B

37.66%1.72B

-3.06%3.13B

64.48%9.81B

69.11%2.4B

70.45%2.93B

Investing cash flow

Cash flow from continuing investing activities

Net PPE purchase and sale

-42.01%-382M

-198.36%-364M

-51.92%-1.23B

-389.72%-524M

-36.52%-314M

-6.32%-269M

44.29%-122M

24.95%-809M

66.56%-107M

9.45%-230M

Net intangibles purchase and sale

-51.32%-286M

-16.06%-1.11B

-105.81%-2.13B

-136.16%-418M

35.19%-560M

18.88%-189M

-497.93%-959M

-97.89%-1.03B

54.85%-177M

-122.11%-864M

Net business purchase and sale

-1,221.74%-2.43B

-120.66%-940M

-11.12%-1.18B

-56.61%-296M

20.18%-273M

36.11%-184M

-76.03%-426M

88.75%-1.06B

13.30%-189M

96.45%-342M

Net investment purchase and sale

109.09%115M

-568.42%-89M

94.02%-7M

-56.84%82M

49.54%-163M

266.67%55M

-61.22%19M

-48.10%-117M

2,211.11%190M

-65.64%-323M

Net other investing changes

----

--190M

--0

--15M

--0

--175M

----

Cash from discontinued investing activities

Investing cash flow

-452.31%-2.87B

-93.66%-2.41B

-37.30%-4.06B

-332.53%-1.08B

29.95%-1.22B

35.00%-520M

-641.67%-1.25B

73.23%-2.96B

72.73%-249M

83.34%-1.74B

Financing cash flow

Cash flow from continuing financing activities

Net issuance payments of debt

21.20%-1.13B

211.10%5.97B

19.38%-965M

24.84%-236M

-2,184.48%-1.21B

-16.24%-1.44B

546.13%1.92B

-115.16%-1.2B

63.19%-314M

-96.37%58M

Net common stock issuance

25.00%5M

50.00%6M

13.79%33M

16.67%21M

33.33%4M

-20.00%4M

0.00%29M

-5.26%18M

200.00%3M

Cash dividends paid

22.73%-17M

0.46%-3.03B

-2.68%-4.48B

---2M

-1.22%-1.41B

---22M

-2.56%-3.05B

-13.17%-4.36B

--0

-0.43%-1.39B

Net other financing activities

--0

-0.12%-841M

15.38%-886M

--0

8.00%-46M

--0

15.75%-840M

-488.20%-1.05B

--0

-733.33%-50M

Cash from discontinued financing activities

Financing cash flow

19.55%-1.22B

199.85%2.03B

3.75%-6.57B

18.72%-291M

-90.63%-2.73B

-17.30%-1.52B

45.70%-2.03B

-286.98%-6.82B

65.94%-358M

-1,107.04%-1.43B

Net cash flow

Beginning cash position

31.98%7.69B

-5.78%5.64B

-0.91%5.98B

10.34%4.62B

22.12%5.47B

8.87%5.83B

-0.91%5.98B

-19.98%6.04B

-36.32%4.19B

-70.52%4.48B

Current changes in cash

-214.33%-1.01B

1,559.03%2.1B

-1,244.00%-286M

-43.50%1.01B

-242.80%-833M

62.10%-321M

78.70%-144M

101.73%25M

428.02%1.79B

97.18%-243M

Effect of exchange rate changes

83.33%-6M

-318.18%-46M

25.00%-60M

0.00%6M

62.75%-19M

-38.46%-36M

-22.22%-11M

-29.03%-80M

-45.45%6M

-142.86%-51M

End cash Position

22.04%6.68B

31.98%7.69B

-5.78%5.64B

10.34%4.62B

22.12%5.47B

8.87%5.83B

-0.91%5.98B

-36.32%4.19B

Free cash flow

95.71%2.42B

-47.02%881M

-9.26%6.57B

-22.23%1.43B

22.87%2.24B

75.18%1.24B

-42.04%1.66B

92.32%7.24B

163.43%1.84B

71.77%1.82B

Currency Unit

USD

Accounting Standards

NonUS-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Net income from continuing operations	14.80%2.4B	23.78%2.8B	175.85%6.9B	15.30%897M	78.98%1.65B	745.34%2.09B	309.04%2.26B	1,043.77%2.5B	222.33%778M	146.13%923M
Other non cash items	73.76%702M	-150.70%-356M	127.07%1.45B	142.04%927M	58.79%262M	308.08%404M	-1,675.00%-142M	-52.38%639M	-49.41%383M	-37.50%165M
Change In working capital	86.96%-129M	-288.02%-455M	-92.01%300M	-49.83%150M	-15.93%897M	-268.48%-989M	-86.59%242M	85.90%3.76B	811.90%299M	-11.53%1.07B
-Change in receivables	----	----	-5.63%-1.43B	----	----	----	----	-40.37%-1.35B	----	----
-Change in inventory	----	----	-116.98%-669M	----	----	----	----	149.90%3.94B	----	----
Cash from discontinued investing activities
Operating cash flow	79.57%3.09B	-20.65%2.49B	5.48%10.35B	-0.75%2.38B	6.28%3.11B	37.66%1.72B	-3.06%3.13B	64.48%9.81B	69.11%2.4B	70.45%2.93B
Investing cash flow
Cash flow from continuing investing activities
Net PPE purchase and sale	-42.01%-382M	-198.36%-364M	-51.92%-1.23B	-389.72%-524M	-36.52%-314M	-6.32%-269M	44.29%-122M	24.95%-809M	66.56%-107M	9.45%-230M
Net intangibles purchase and sale	-51.32%-286M	-16.06%-1.11B	-105.81%-2.13B	-136.16%-418M	35.19%-560M	18.88%-189M	-497.93%-959M	-97.89%-1.03B	54.85%-177M	-122.11%-864M
Net business purchase and sale	-1,221.74%-2.43B	-120.66%-940M	-11.12%-1.18B	-56.61%-296M	20.18%-273M	36.11%-184M	-76.03%-426M	88.75%-1.06B	13.30%-189M	96.45%-342M
Net investment purchase and sale	109.09%115M	-568.42%-89M	94.02%-7M	-56.84%82M	49.54%-163M	266.67%55M	-61.22%19M	-48.10%-117M	2,211.11%190M	-65.64%-323M
Net other investing changes	----	----	--190M	--0	--15M	--0	--175M	----	----	----
Cash from discontinued investing activities
Investing cash flow	-452.31%-2.87B	-93.66%-2.41B	-37.30%-4.06B	-332.53%-1.08B	29.95%-1.22B	35.00%-520M	-641.67%-1.25B	73.23%-2.96B	72.73%-249M	83.34%-1.74B
Financing cash flow
Cash flow from continuing financing activities
Net issuance payments of debt	21.20%-1.13B	211.10%5.97B	19.38%-965M	24.84%-236M	-2,184.48%-1.21B	-16.24%-1.44B	546.13%1.92B	-115.16%-1.2B	63.19%-314M	-96.37%58M
Net common stock issuance	25.00%5M	50.00%6M	13.79%33M	16.67%21M	33.33%4M	33.33%4M	-20.00%4M	0.00%29M	-5.26%18M	200.00%3M
Cash dividends paid	22.73%-17M	0.46%-3.03B	-2.68%-4.48B	---2M	-1.22%-1.41B	---22M	-2.56%-3.05B	-13.17%-4.36B	--0	-0.43%-1.39B
Net other financing activities	--0	-0.12%-841M	15.38%-886M	--0	8.00%-46M	--0	15.75%-840M	-488.20%-1.05B	--0	-733.33%-50M
Cash from discontinued financing activities
Financing cash flow	19.55%-1.22B	199.85%2.03B	3.75%-6.57B	18.72%-291M	-90.63%-2.73B	-17.30%-1.52B	45.70%-2.03B	-286.98%-6.82B	65.94%-358M	-1,107.04%-1.43B
Net cash flow
Beginning cash position	31.98%7.69B	-5.78%5.64B	-0.91%5.98B	10.34%4.62B	22.12%5.47B	8.87%5.83B	-0.91%5.98B	-19.98%6.04B	-36.32%4.19B	-70.52%4.48B
Current changes in cash	-214.33%-1.01B	1,559.03%2.1B	-1,244.00%-286M	-43.50%1.01B	-242.80%-833M	62.10%-321M	78.70%-144M	101.73%25M	428.02%1.79B	97.18%-243M
Effect of exchange rate changes	83.33%-6M	-318.18%-46M	25.00%-60M	0.00%6M	62.75%-19M	-38.46%-36M	-22.22%-11M	-29.03%-80M	-45.45%6M	-142.86%-51M
End cash Position	22.04%6.68B	31.98%7.69B	-5.78%5.64B	-5.78%5.64B	10.34%4.62B	22.12%5.47B	8.87%5.83B	-0.91%5.98B	-0.91%5.98B	-36.32%4.19B
Free cash flow	95.71%2.42B	-47.02%881M	-9.26%6.57B	-22.23%1.43B	22.87%2.24B	75.18%1.24B	-42.04%1.66B	92.32%7.24B	163.43%1.84B	71.77%1.82B
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall